Category Archives: Bl-9020 Monoclonal Antibody

Asian Companies to Collaborate on Type 1 Antibody Treatment

Two Asian companies–BioLineRx of Israel and JHL Biotech of Taiwan–have agreed to collaborate on the development and marketing of BL-9020, a monoclonal antibody that could become a significant means of treatment for early-stage type 1 diabetes.

BL-9020 targets Natural Killer …